TRACHILID

This brand name is authorized in Estonia, Lithuania.

Active ingredients

The drug TRACHILID contains one active pharmaceutical ingredient (API):

1	Lidocaine hydrochloride monohydrate UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R02AD02	Lidocaine	R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AD Anesthetics, local
Discover more medicines within R02AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1255700, 1255711, 1255722, 1255733, 1255744, 1255755, 1255766, 1255777, 1255788, 1255799, 1255801, 1255812, 1255823
LT	Valstybinė vaistų kontrolės tarnyba	1023621, 1033987, 1033988, 1033989, 1033990, 1033991, 1033992, 1033993, 1033994, 1033995, 1033996, 1033997, 1033998